TY - JOUR AU - Zhu, A X; Rosmorduc, O; Evans, J TI - SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with hepatocellular carcinoma (HCC) JO - Ann Oncol IS - S09 VL - 23 PY - 2012 N1 - Abstract LBA2 ER -